Last 12 months
Inside the activity.
1 purchase rows · 23 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 2 |
| Dec 2025 | 0 | 5 |
| Jan 2026 | 0 | 2 |
| Feb 2026 | 0 | 2 |
| Mar 2026 | 1 | 1 |
| Apr 2026 | 0 | 3 |
| May 2026 | 0 | 2 |
| Jun 2026 | 0 | 1 |
| Jul 2026 | 0 | 1 |
| Aug 2026 | 0 | 3 |
| Sep 2026 | 0 | 1 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| October 01, 2018 Filed Oct 3, 2018 18:40 UTC |
Sullivan DonSVP & GM, Ind. Products
|
Tax withholdingCommon Stock | 1,300 | $53.32 | $69,316.00 |
DisclosureSEC source: 0001593968-18-001304 · primary_01.xml · nonDerivative · entry 2 Sullivan Don · CIK 0001663176 · SVP & GM, Ind. Products 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,870 F1 · security: RSA with 3 Year Annual vesting schedule Read SEC document |
| October 01, 2018 Filed Oct 3, 2018 18:40 UTC |
Sullivan DonSVP & GM, Ind. Products
|
GrantCommon Stock | 2,606 | $0.00 | $0.00 |
DisclosureSEC source: 0001593968-18-001304 · primary_01.xml · nonDerivative · entry 1 Sullivan Don · CIK 0001663176 · SVP & GM, Ind. Products 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,170 F1 · security: RSA with 3 Year Annual vesting schedule F2 · price: Represents shares of restricted common stock granted to the reporting person pursuant to the issuer's Equity and Incentive Compensation Plan. The shares vest ratably over a three-year period on each annual anniversary of the grant. Read SEC document |
| October 01, 2018 Filed Oct 3, 2018 18:39 UTC |
LIVINGSTONE LINDA A.Director
|
GrantCommon Stock | 1,595 | $0.00 | $0.00 |
DisclosureSEC source: 0001593968-18-001303 · primary_01.xml · nonDerivative · entry 1 LIVINGSTONE LINDA A. · CIK 0001652531 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,037 F1 · price: Represents shares of restricted common stock granted to the reporting person pursuant to the issuer's Equity and Incentive Compensation Plan. The shares cliff vest on the first anniversary of the grant. Read SEC document |
| August 17, 2018 Filed Aug 17, 2018 19:49 UTC |
Armes Joseph BDirector · Chairman, President & CEO
|
GiftCommon Stock | 943 | $0.00 | $0.00 |
DisclosureSEC source: 0001593968-18-001124 · primary_01.xml · nonDerivative · entry 1 Armes Joseph B · CIK 0001413614 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 65,967 F1 · shares: Represents shares donated by the Reporting Person to a charitable donor advised fund. Read SEC document |
| July 15, 2018 Filed Jul 17, 2018 20:53 UTC |
Armes Joseph BDirector · Chairman, President & CEO
|
Tax withholdingCommon Stock | 530 | $52.90 | $28,037.00 |
DisclosureSEC source: 0001593968-18-001061 · primary_01.xml · nonDerivative · entry 1 Armes Joseph B · CIK 0001413614 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 66,910 Read SEC document |
| July 06, 2018 Filed Jul 9, 2018 23:11 UTC |
Armes Joseph BDirector · Chairman, President & CEO
|
SaleCommon Stock | 4,250 | $53.80 | $228,650.00 |
DisclosureSEC source: 0001593968-18-001030 · primary_01.xml · nonDerivative · entry 1 Armes Joseph B · CIK 0001413614 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 67,440 F1 · kind: The transaction reported was effected pursuant to a 10b5-1 trading plan established by the reporting person on December 8, 2017. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $53.65 to $54.00, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| June 09, 2018 Filed Jun 11, 2018 12:34 UTC |
Branning Greggory WEVP, CFO
|
Tax withholdingCommon Stock | 243 | $0.00 | $0.00 |
DisclosureSEC source: 0001593968-18-000887 · primary_01.xml · nonDerivative · entry 1 Branning Greggory W · CIK 0001557808 · EVP, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,702 F1 · security: RSA with 3 Year Annual vesting schedule Read SEC document |
| June 05, 2018 Filed Jun 5, 2018 20:18 UTC |
Alverson LukeSVP, GC & Secretary
|
GiftCommon Stock | 300 | $0.00 | $0.00 |
DisclosureSEC source: 0001593968-18-000855 · primary_01.xml · nonDerivative · entry 1 Alverson Luke · CIK 0001668461 · SVP, GC & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,930 F1 · acquired: Represents shares donated by the Reporting Person to a charitable donor advised fund. Read SEC document |
| April 17, 2018 Filed Apr 17, 2018 21:03 UTC |
Armes Joseph BDirector · Chairman & CEO
|
SaleCommon Stock | 4,250 | $45.29 | $192,482.50 |
DisclosureSEC source: 0001593968-18-000680 · primary_01.xml · nonDerivative · entry 1 Armes Joseph B · CIK 0001413614 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,689 F1 · kind: The transaction reported was effected pursuant to a 10b5-1 trading plan established by the reporting person on December 8, 2017. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $45.125 to $45.50, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| April 13, 2018 Filed Apr 17, 2018 17:08 UTC |
Armes Joseph BDirector · Chairman & CEO
|
Exercise / conversionPerformance Rights · Derivative | 11,363 | $0.00 | $0.00 |
DisclosureSEC source: 0001593968-18-000679 · primary_01.xml · derivative · entry 3 Armes Joseph B · CIK 0001413614 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,320 Underlying: Common Stock · 11,363 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each performance right represents a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vest at a rate between 0% and 100% during a three-year performance cycle beginning on October 1, 2015 and ending on March 31, 2018 based on the issuer's relative total shareholder return in comparison to the total shareholder return performance among a predetermined peer group over the performance cycle. The performance rights may be settled, at the issuer's discretion, in cash or shares of common stock. F2 · derivative.exercise_date: Each performance right represents a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vest at a rate between 0% and 100% during a three-year performance cycle beginning on October 1, 2015 and ending on March 31, 2018 based on the issuer's relative total shareholder return in comparison to the total shareholder return performance among a predetermined peer group over the performance cycle. The performance rights may be settled, at the issuer's discretion, in cash or shares of common stock. F2 · derivative.expiration_date: Each performance right represents a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vest at a rate between 0% and 100% during a three-year performance cycle beginning on October 1, 2015 and ending on March 31, 2018 based on the issuer's relative total shareholder return in comparison to the total shareholder return performance among a predetermined peer group over the performance cycle. The performance rights may be settled, at the issuer's discretion, in cash or shares of common stock. Read SEC document |
| April 13, 2018 Filed Apr 17, 2018 17:08 UTC |
Armes Joseph BDirector · Chairman & CEO
|
Tax withholdingCommon Stock | 2,094 | $44.90 | $94,020.60 |
DisclosureSEC source: 0001593968-18-000679 · primary_01.xml · nonDerivative · entry 2 Armes Joseph B · CIK 0001413614 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,507 Read SEC document |
| April 13, 2018 Filed Apr 17, 2018 17:08 UTC |
Armes Joseph BDirector · Chairman & CEO
|
Exercise / conversionCommon Stock | 7,954 | $0.00 | $0.00 |
DisclosureSEC source: 0001593968-18-000679 · primary_01.xml · nonDerivative · entry 1 Armes Joseph B · CIK 0001413614 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,601 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 09, 2018 Filed Apr 11, 2018 14:33 UTC |
Alverson LukeSVP, GC & Secretary
|
GrantPerformance Rights · Derivative | 2,750 | $0.00 | $0.00 |
DisclosureSEC source: 0001593968-18-000667 · primary_01.xml · derivative · entry 1 Alverson Luke · CIK 0001668461 · SVP, GC & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,951 Underlying: Common Stock · 2,750 shares Expires not disclosed F1 · derivative.exercise_price: Each performance right represents a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vest at a rate between 0% and 200% during a three-year performance cycle beginning on April 1, 2018 and ending on March 31, 2021 based on the issuer's relative total shareholder return in comparison to the total shareholder return performance among the Russell 2000 Index over the performance cycle. The performance rights may be settled, at the issuer's discretion, in cash or shares of common stock. F1 · derivative.exercise_date: Each performance right represents a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vest at a rate between 0% and 200% during a three-year performance cycle beginning on April 1, 2018 and ending on March 31, 2021 based on the issuer's relative total shareholder return in comparison to the total shareholder return performance among the Russell 2000 Index over the performance cycle. The performance rights may be settled, at the issuer's discretion, in cash or shares of common stock. F1 · derivative.expiration_date: Each performance right represents a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vest at a rate between 0% and 200% during a three-year performance cycle beginning on April 1, 2018 and ending on March 31, 2021 based on the issuer's relative total shareholder return in comparison to the total shareholder return performance among the Russell 2000 Index over the performance cycle. The performance rights may be settled, at the issuer's discretion, in cash or shares of common stock. Read SEC document |
| April 09, 2018 Filed Apr 11, 2018 14:28 UTC |
Armes Joseph BDirector · Chairman & CEO
|
GrantPerformance Rights · Derivative | 15,554 | $0.00 | $0.00 |
DisclosureSEC source: 0001593968-18-000664 · primary_01.xml · derivative · entry 1 Armes Joseph B · CIK 0001413614 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 68,683 Underlying: Common Stock · 15,554 shares Expires not disclosed F1 · derivative.exercise_price: Each performance right represents a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vest at a rate between 0% and 200% during a three-year performance cycle beginning on April 1, 2018 and ending on March 31, 2021 based on the issuer's relative total shareholder return in comparison to the total shareholder return performance among the Russell 2000 Index over the performance cycle. The performance rights may be settled, at the issuer's discretion, in cash or shares of common stock. F1 · derivative.exercise_date: Each performance right represents a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vest at a rate between 0% and 200% during a three-year performance cycle beginning on April 1, 2018 and ending on March 31, 2021 based on the issuer's relative total shareholder return in comparison to the total shareholder return performance among the Russell 2000 Index over the performance cycle. The performance rights may be settled, at the issuer's discretion, in cash or shares of common stock. F1 · derivative.expiration_date: Each performance right represents a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vest at a rate between 0% and 200% during a three-year performance cycle beginning on April 1, 2018 and ending on March 31, 2021 based on the issuer's relative total shareholder return in comparison to the total shareholder return performance among the Russell 2000 Index over the performance cycle. The performance rights may be settled, at the issuer's discretion, in cash or shares of common stock. Read SEC document |
| April 09, 2018 Filed Apr 11, 2018 10:27 UTC |
Branning Greggory WEVP, CFO
|
GrantPerformance Rights · Derivative | 4,433 | $0.00 | $0.00 |
DisclosureSEC source: 0001593968-18-000663 · primary_01.xml · derivative · entry 1 Branning Greggory W · CIK 0001557808 · EVP, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,925 Underlying: Common Stock · 4,433 shares Expires not disclosed F1 · derivative.exercise_price: Each performance right represents a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vest at a rate between 0% and 200% during a three-year performance cycle beginning on April 1, 2018 and ending on March 31, 2021 based on the issuer's relative total shareholder return in comparison to the total shareholder return performance among the Russell 2000 Index over the performance cycle. The performance rights may be settled, at the issuer's discretion, in cash or shares of common stock. F1 · derivative.exercise_date: Each performance right represents a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vest at a rate between 0% and 200% during a three-year performance cycle beginning on April 1, 2018 and ending on March 31, 2021 based on the issuer's relative total shareholder return in comparison to the total shareholder return performance among the Russell 2000 Index over the performance cycle. The performance rights may be settled, at the issuer's discretion, in cash or shares of common stock. F1 · derivative.expiration_date: Each performance right represents a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vest at a rate between 0% and 200% during a three-year performance cycle beginning on April 1, 2018 and ending on March 31, 2021 based on the issuer's relative total shareholder return in comparison to the total shareholder return performance among the Russell 2000 Index over the performance cycle. The performance rights may be settled, at the issuer's discretion, in cash or shares of common stock. Read SEC document |
| April 09, 2018 Filed Apr 11, 2018 14:32 UTC |
Sullivan DonSVP & GM, Ind. Products
|
GrantPerformance Rights · Derivative | 2,147 | $0.00 | $0.00 |
DisclosureSEC source: 0001593968-18-000666 · primary_01.xml · derivative · entry 1 Sullivan Don · CIK 0001663176 · SVP & GM, Ind. Products 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,628 Underlying: Common Stock · 2,147 shares Expires not disclosed F1 · derivative.exercise_price: Each performance right represents a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vest at a rate between 0% and 200% during a three-year performance cycle beginning on April 1, 2018 and ending on March 31, 2021 based on the issuer's relative total shareholder return in comparison to the total shareholder return performance among the Russell 2000 Index over the performance cycle. The performance rights may be settled, at the issuer's discretion, in cash or shares of common stock. F1 · derivative.exercise_date: Each performance right represents a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vest at a rate between 0% and 200% during a three-year performance cycle beginning on April 1, 2018 and ending on March 31, 2021 based on the issuer's relative total shareholder return in comparison to the total shareholder return performance among the Russell 2000 Index over the performance cycle. The performance rights may be settled, at the issuer's discretion, in cash or shares of common stock. F1 · derivative.expiration_date: Each performance right represents a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vest at a rate between 0% and 200% during a three-year performance cycle beginning on April 1, 2018 and ending on March 31, 2021 based on the issuer's relative total shareholder return in comparison to the total shareholder return performance among the Russell 2000 Index over the performance cycle. The performance rights may be settled, at the issuer's discretion, in cash or shares of common stock. Read SEC document |
| April 09, 2018 Filed Apr 11, 2018 14:31 UTC |
Foster Craig JamesSVP & GM, Spec. Chem.
|
GrantPerformance Rights · Derivative | 3,207 | $0.00 | $0.00 |
DisclosureSEC source: 0001593968-18-000665 · primary_01.xml · derivative · entry 1 Foster Craig James · CIK 0001663184 · SVP & GM, Spec. Chem. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,458 Underlying: Common Stock · 3,207 shares Expires not disclosed F1 · derivative.exercise_price: Each performance right represents a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vest at a rate between 0% and 200% during a three-year performance cycle beginning on April 1, 2018 and ending on March 31, 2021 based on the issuer's relative total shareholder return in comparison to the total shareholder return performance among the Russell 2000 Index over the performance cycle. The performance rights may be settled, at the issuer's discretion, in cash or shares of common stock. F1 · derivative.exercise_date: Each performance right represents a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vest at a rate between 0% and 200% during a three-year performance cycle beginning on April 1, 2018 and ending on March 31, 2021 based on the issuer's relative total shareholder return in comparison to the total shareholder return performance among the Russell 2000 Index over the performance cycle. The performance rights may be settled, at the issuer's discretion, in cash or shares of common stock. F1 · derivative.expiration_date: Each performance right represents a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vest at a rate between 0% and 200% during a three-year performance cycle beginning on April 1, 2018 and ending on March 31, 2021 based on the issuer's relative total shareholder return in comparison to the total shareholder return performance among the Russell 2000 Index over the performance cycle. The performance rights may be settled, at the issuer's discretion, in cash or shares of common stock. Read SEC document |
| February 28, 2018 Filed Mar 2, 2018 19:18 UTC |
Alverson LukeSVP, GC & Secretary
|
Tax withholdingCommon Stock | 520 | $0.00 | $0.00 |
DisclosureSEC source: 0001593968-18-000461 · primary_01.xml · nonDerivative · entry 1 Alverson Luke · CIK 0001668461 · SVP, GC & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,230 F1 · security: RSA with 3 Year Annual vesting schedule Read SEC document |
| February 12, 2018 Filed Feb 13, 2018 21:03 UTC |
Armes Joseph BDirector · Chairman & CEO
|
SaleCommon Stock | 4,250 | $45.89 | $195,032.50 |
DisclosureSEC source: 0001593968-18-000341 · primary_01.xml · nonDerivative · entry 1 Armes Joseph B · CIK 0001413614 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 69,079 F1 · kind: The transaction reported was effected pursuant to a 10b5-1 trading plan established by the reporting person on December 8, 2017. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $45.65 to $46.48, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| January 04, 2018 Filed Jan 8, 2018 14:11 UTC |
Foster Craig JamesSVP & GM, Spec. Chem.
|
Tax withholdingCommon Stock | 206 | $45.90 | $9,455.40 |
DisclosureSEC source: 0001593968-18-000116 · primary_01.xml · nonDerivative · entry 1 Foster Craig James · CIK 0001663184 · SVP & GM, Spec. Chem. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,304 F1 · security: RSA with 3 Year Annual vesting schedule Read SEC document |
| December 29, 2017 Filed Jan 2, 2018 16:03 UTC |
Armes Joseph BDirector · Chairman & CEO
|
Tax withholdingCommon Stock | 7,989 | $45.95 | $367,094.55 |
DisclosureSEC source: 0001593968-18-000001 · primary_01.xml · nonDerivative · entry 1 Armes Joseph B · CIK 0001413614 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,897 Read SEC document |
| November 29, 2017 Filed Nov 29, 2017 16:36 UTC |
Armes Joseph BDirector · Chairman & CEO
|
GiftCommon Stock | 2,200 | $0.00 | $0.00 |
DisclosureSEC source: 0001593968-17-001275 · primary_01.xml · nonDerivative · entry 1 Armes Joseph B · CIK 0001413614 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 61,886 F1 · acquired: Represents shares donated by the Reporting Person to a charitable donor advised fund. Read SEC document |
| October 01, 2017 Filed Oct 2, 2017 10:08 UTC |
QUINN WILLIAM FDirector
|
GrantCommon Stock | 1,691 | $44.35 | $74,995.85 |
DisclosureSEC source: 0001593968-17-001074 · primary_01.xml · nonDerivative · entry 1 QUINN WILLIAM F · CIK 0001035219 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,832 F1 · price: Represents shares of restricted common stock granted to the reporting person pursuant to the issuer's Equity and Incentive Compensation Plan. The shares cliff vest on the first anniversary of the grant. Read SEC document |
| October 01, 2017 Filed Oct 2, 2017 10:11 UTC |
Sweezey Jay KentDirector
|
GrantCommon Stock | 1,691 | $44.35 | $74,995.85 |
DisclosureSEC source: 0001593968-17-001075 · primary_01.xml · nonDerivative · entry 1 Sweezey Jay Kent · CIK 0001691674 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,250 F1 · price: Represents shares of restricted common stock granted to the reporting person pursuant to the issuer's Equity and Incentive Compensation Plan. The shares cliff vest on the first anniversary of the grant. Read SEC document |
| October 01, 2017 Filed Oct 2, 2017 19:04 UTC |
Alverson LukeSVP, GC & Secretary
|
Tax withholdingCommon Stock | 212 | $44.35 | $9,402.20 |
DisclosureSEC source: 0001593968-17-001078 · primary_01.xml · nonDerivative · entry 2 Alverson Luke · CIK 0001668461 · SVP, GC & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,750 F1 · security: RSA with 3 Year Annual vesting schedule Read SEC document |
| October 01, 2017 Filed Oct 2, 2017 19:04 UTC |
Alverson LukeSVP, GC & Secretary
|
GrantCommon Stock | 2,957 | $0.00 | $0.00 |
DisclosureSEC source: 0001593968-17-001078 · primary_01.xml · nonDerivative · entry 1 Alverson Luke · CIK 0001668461 · SVP, GC & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,962 F1 · security: RSA with 3 Year Annual vesting schedule F2 · price: Represents shares of restricted common stock granted to the reporting person pursuant to the issuer's Equity and Incentive Compensation Plan. The shares vest ratably over a three-year period on each annual anniversary of the grant. Read SEC document |
| October 01, 2017 Filed Oct 2, 2017 19:01 UTC |
Armes Joseph BDirector · Chairman & CEO
|
Tax withholdingCommon Stock | 6,185 | $44.35 | $274,304.75 |
DisclosureSEC source: 0001593968-17-001077 · primary_01.xml · nonDerivative · entry 2 Armes Joseph B · CIK 0001413614 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 64,086 Read SEC document |
| October 01, 2017 Filed Oct 2, 2017 19:01 UTC |
Armes Joseph BDirector · Chairman & CEO
|
GrantCommon Stock | 18,046 | $0.00 | $0.00 |
DisclosureSEC source: 0001593968-17-001077 · primary_01.xml · nonDerivative · entry 1 Armes Joseph B · CIK 0001413614 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,271 F1 · price: Represents shares of restricted common stock granted to the reporting person pursuant to the issuer's Equity and Incentive Compensation Plan. The shares vest ratably over a three-year period on each annual anniversary of the grant. Read SEC document |
| October 01, 2017 Filed Oct 2, 2017 10:05 UTC |
Swartz Robert MDirector
|
GrantCommon Stock | 1,691 | $44.35 | $74,995.85 |
DisclosureSEC source: 0001593968-17-001072 · primary_01.xml · nonDerivative · entry 1 Swartz Robert M · CIK 0001413221 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,443 F1 · price: Represents shares of restricted common stock granted to the reporting person pursuant to the issuer's Equity and Incentive Compensation Plan. The shares cliff vest on the first anniversary of the grant. Read SEC document |
| October 01, 2017 Filed Oct 2, 2017 14:02 UTC |
GAMBRELL MICHAEL RDirector
|
GrantCommon Stock | 1,691 | $44.35 | $74,995.85 |
DisclosureSEC source: 0001593968-17-001071 · primary_01.xml · nonDerivative · entry 1 GAMBRELL MICHAEL R · CIK 0001277031 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,442 F1 · price: Represents shares of restricted common stock granted to the reporting person pursuant to the issuer's Equity and Incentive Compensation Plan. The shares cliff vest on the first anniversary of the grant. Read SEC document |
| October 01, 2017 Filed Oct 2, 2017 15:06 UTC |
Branning Greggory WEVP, CFO
|
Tax withholdingCommon Stock | 561 | $44.35 | $24,880.35 |
DisclosureSEC source: 0001593968-17-001080 · primary_01.xml · nonDerivative · entry 2 Branning Greggory W · CIK 0001557808 · EVP, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,945 F1 · security: RSA with 3 Year Annual vesting schedule Read SEC document |
| October 01, 2017 Filed Oct 2, 2017 15:06 UTC |
Branning Greggory WEVP, CFO
|
GrantCommon Stock | 5,156 | $0.00 | $0.00 |
DisclosureSEC source: 0001593968-17-001080 · primary_01.xml · nonDerivative · entry 1 Branning Greggory W · CIK 0001557808 · EVP, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,506 F1 · security: RSA with 3 Year Annual vesting schedule F2 · price: Represents shares of restricted common stock granted to the reporting person pursuant to the issuer's Equity and Incentive Compensation Plan. The shares vest ratably over a three-year period on each annual anniversary of the grant. Read SEC document |
| October 01, 2017 Filed Oct 2, 2017 14:06 UTC |
JOHNSTON TERRY LDirector
|
GrantCommon Stock | 1,691 | $44.35 | $74,995.85 |
DisclosureSEC source: 0001593968-17-001073 · primary_01.xml · nonDerivative · entry 1 JOHNSTON TERRY L · CIK 0001565364 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,016 F1 · price: Represents shares of restricted common stock granted to the reporting person pursuant to the issuer's Equity and Incentive Compensation Plan. The shares cliff vest on the first annual anniversary of the grant. Read SEC document |
| October 01, 2017 Filed Oct 2, 2017 19:08 UTC |
MUDD CHRISTOPHER JPresident and COO
|
Tax withholdingCommon Stock | 1,210 | $44.35 | $53,663.50 |
DisclosureSEC source: 0001593968-17-001082 · primary_01.xml · nonDerivative · entry 2 MUDD CHRISTOPHER J · CIK 0001630422 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,304 Read SEC document |
| October 01, 2017 Filed Oct 2, 2017 19:08 UTC |
MUDD CHRISTOPHER JPresident and COO
|
GrantCommon Stock | 5,854 | $0.00 | $0.00 |
DisclosureSEC source: 0001593968-17-001082 · primary_01.xml · nonDerivative · entry 1 MUDD CHRISTOPHER J · CIK 0001630422 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,514 F1 · price: Represents shares of restricted common stock granted to the reporting person pursuant to the issuer's Equity and Incentive Compensation Plan. The shares vest ratably over a three-year period on each annual anniversary of the grant. Read SEC document |
| October 01, 2017 Filed Oct 2, 2017 19:07 UTC |
Sullivan DonSVP & GM, Ind. Products
|
Tax withholdingCommon Stock | 472 | $44.35 | $20,933.20 |
DisclosureSEC source: 0001593968-17-001081 · primary_01.xml · nonDerivative · entry 2 Sullivan Don · CIK 0001663176 · SVP & GM, Ind. Products 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,564 Read SEC document |
| October 01, 2017 Filed Oct 2, 2017 19:07 UTC |
Sullivan DonSVP & GM, Ind. Products
|
GrantCommon Stock | 5,086 | $0.00 | $0.00 |
DisclosureSEC source: 0001593968-17-001081 · primary_01.xml · nonDerivative · entry 1 Sullivan Don · CIK 0001663176 · SVP & GM, Ind. Products 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,036 F1 · price: Represents shares of restricted common stock granted to the reporting person pursuant to the issuer's Equity and Incentive Compensation Plan. The shares vest ratably over a three-year period on each annual anniversary of the grant. Read SEC document |
| October 01, 2017 Filed Oct 2, 2017 19:05 UTC |
Foster Craig JamesSVP & GM, Spec. Chem.
|
Tax withholdingCommon Stock | 200 | $44.35 | $8,870.00 |
DisclosureSEC source: 0001593968-17-001079 · primary_01.xml · nonDerivative · entry 2 Foster Craig James · CIK 0001663184 · SVP & GM, Spec. Chem. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,510 F1 · security: RSA with 3 Year Annual vesting schedule Read SEC document |
| October 01, 2017 Filed Oct 2, 2017 19:05 UTC |
Foster Craig JamesSVP & GM, Spec. Chem.
|
GrantCommon Stock | 1,837 | $0.00 | $0.00 |
DisclosureSEC source: 0001593968-17-001079 · primary_01.xml · nonDerivative · entry 1 Foster Craig James · CIK 0001663184 · SVP & GM, Spec. Chem. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,710 F1 · security: RSA with 3 Year Annual vesting schedule F2 · price: Represents shares of restricted common stock granted to the reporting person pursuant to the issuer's Equity and Incentive Compensation Plan. The shares vest ratably over a three-year period on each annual anniversary of the grant. Read SEC document |
| October 01, 2017 Filed Oct 2, 2017 14:12 UTC |
LIVINGSTONE LINDA A.Director
|
GrantCommon Stock | 1,691 | $44.35 | $74,995.85 |
DisclosureSEC source: 0001593968-17-001076 · primary_01.xml · nonDerivative · entry 1 LIVINGSTONE LINDA A. · CIK 0001652531 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,442 F1 · price: Represents shares of restricted common stock granted to the reporting person pursuant to the issuer's Equity and Incentive Compensation Plan. The shares cliff vest on the first anniversary of the grant. Read SEC document |
| August 15, 2017 Filed Aug 16, 2017 15:41 UTC |
Armes Joseph BDirector · Chairman & CEO
|
GiftCommon Stock | 2,311 | $0.00 | $0.00 |
DisclosureSEC source: 0001593968-17-000994 · primary_01.xml · nonDerivative · entry 1 Armes Joseph B · CIK 0001413614 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,225 F1 · acquired: Represents shares donated by the Reporting Person to a charitable donor advised fund. Read SEC document |
| July 14, 2017 Filed Jul 14, 2017 20:20 UTC |
Armes Joseph BDirector · Chairman & CEO
|
Tax withholdingCommon Stock | 385 | $39.55 | $15,226.75 |
DisclosureSEC source: 0001593968-17-000933 · primary_01.xml · nonDerivative · entry 1 Armes Joseph B · CIK 0001413614 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,536 Read SEC document |
| June 09, 2017 Filed Jun 12, 2017 11:24 UTC |
Branning Greggory WEVP, CFO
|
Tax withholdingCommon Stock | 274 | $0.00 | $0.00 |
DisclosureSEC source: 0001593968-17-000777 · primary_01.xml · nonDerivative · entry 1 Branning Greggory W · CIK 0001557808 · EVP, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,350 F1 · security: RSA with 3 Year Annual vesting schedule Read SEC document |
| April 05, 2017 Filed Apr 5, 2017 22:23 UTC |
Alverson LukeSVP, GC & Secretary
|
GrantPerformance Rights · Derivative | 3,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001593968-17-000584 · primary_01.xml · derivative · entry 1 Alverson Luke · CIK 0001668461 · SVP, GC & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,201 Underlying: Common Stock · 3,000 shares Expires not disclosed F1 · derivative.exercise_price: Each performance right represents a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vest at a rate between 0% and 200% during a three-year performance cycle beginning on April 1, 2017 and ending on March 31, 2020 based on the issuer's relative total shareholder return in comparison to the total shareholder return performance among the Russell 2000 Index over the performance cycle. The performance rights may be settled, at the issuer's discretion, in cash or shares of common stock. F2 · derivative.exercise_date: Each performance right represents a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vest at a rate between 0% and 200% during a three-year performance cycle beginning on April 1, 2017 and ending on March 31, 2020 based on the issuer's relative total shareholder return in comparison to the total shareholder return performance among the Russell 2000 Index over the performance cycle. The performance rights may be settled, at the issuer's discretion, in cash or shares of common stock. F2 · derivative.expiration_date: Each performance right represents a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vest at a rate between 0% and 200% during a three-year performance cycle beginning on April 1, 2017 and ending on March 31, 2020 based on the issuer's relative total shareholder return in comparison to the total shareholder return performance among the Russell 2000 Index over the performance cycle. The performance rights may be settled, at the issuer's discretion, in cash or shares of common stock. Read SEC document |
| April 05, 2017 Filed Apr 5, 2017 22:19 UTC |
Armes Joseph BDirector · Chairman & CEO
|
GrantPerformance Rights · Derivative | 19,359 | $0.00 | $0.00 |
DisclosureSEC source: 0001593968-17-000582 · primary_01.xml · derivative · entry 1 Armes Joseph B · CIK 0001413614 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,129 Underlying: Common Stock · 19,359 shares Expires not disclosed F1 · derivative.exercise_price: Each performance right represents a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vest at a rate between 0% and 200% during a three-year performance cycle beginning on April 1, 2017 and ending on March 31, 2020 based on the issuer's relative total shareholder return in comparison to the total shareholder return performance among the Russell 2000 Index over the performance cycle. The performance rights may be settled, at the issuer's discretion, in cash or shares of common stock. F2 · derivative.exercise_date: Each performance right represents a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vest at a rate between 0% and 200% during a three-year performance cycle beginning on April 1, 2017 and ending on March 31, 2020 based on the issuer's relative total shareholder return in comparison to the total shareholder return performance among the Russell 2000 Index over the performance cycle. The performance rights may be settled, at the issuer's discretion, in cash or shares of common stock. F2 · derivative.expiration_date: Each performance right represents a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vest at a rate between 0% and 200% during a three-year performance cycle beginning on April 1, 2017 and ending on March 31, 2020 based on the issuer's relative total shareholder return in comparison to the total shareholder return performance among the Russell 2000 Index over the performance cycle. The performance rights may be settled, at the issuer's discretion, in cash or shares of common stock. Read SEC document |
| April 05, 2017 Filed Apr 5, 2017 18:17 UTC |
Branning Greggory WEVP, CFO
|
GrantPerformance Rights · Derivative | 5,531 | $0.00 | $0.00 |
DisclosureSEC source: 0001593968-17-000581 · primary_01.xml · derivative · entry 1 Branning Greggory W · CIK 0001557808 · EVP, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,492 Underlying: Common Stock · 5,531 shares Expires not disclosed F1 · derivative.exercise_price: Each performance right represents a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vest at a rate between 0% and 200% during a three-year performance cycle beginning on April 1, 2017 and ending on March 31, 2020 based on the issuer's relative total shareholder return in comparison to the total shareholder return performance among the Russell 2000 Index over the performance cycle. The performance rights may be settled, at the issuer's discretion, in cash or shares of common stock. F2 · derivative.exercise_date: Each performance right represents a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vest at a rate between 0% and 200% during a three-year performance cycle beginning on April 1, 2017 and ending on March 31, 2020 based on the issuer's relative total shareholder return in comparison to the total shareholder return performance among the Russell 2000 Index over the performance cycle. The performance rights may be settled, at the issuer's discretion, in cash or shares of common stock. F2 · derivative.expiration_date: Each performance right represents a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vest at a rate between 0% and 200% during a three-year performance cycle beginning on April 1, 2017 and ending on March 31, 2020 based on the issuer's relative total shareholder return in comparison to the total shareholder return performance among the Russell 2000 Index over the performance cycle. The performance rights may be settled, at the issuer's discretion, in cash or shares of common stock. Read SEC document |
| April 05, 2017 Filed Apr 5, 2017 22:22 UTC |
Foster Craig JamesSVP & GM, Spec. Chem.
|
GrantPerformance Rights · Derivative | 1,970 | $0.00 | $0.00 |
DisclosureSEC source: 0001593968-17-000583 · primary_01.xml · derivative · entry 1 Foster Craig James · CIK 0001663184 · SVP & GM, Spec. Chem. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,251 Underlying: Common Stock · 1,970 shares Expires not disclosed F1 · derivative.exercise_price: Each performance right represents a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vest at a rate between 0% and 200% during a three-year performance cycle beginning on April 1, 2017 and ending on March 31, 2020 based on the issuer's relative total shareholder return in comparison to the total shareholder return performance among the Russell 2000 Index over the performance cycle. The performance rights may be settled, at the issuer's discretion, in cash or shares of common stock. F2 · derivative.exercise_date: Each performance right represents a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vest at a rate between 0% and 200% during a three-year performance cycle beginning on April 1, 2017 and ending on March 31, 2020 based on the issuer's relative total shareholder return in comparison to the total shareholder return performance among the Russell 2000 Index over the performance cycle. The performance rights may be settled, at the issuer's discretion, in cash or shares of common stock. F2 · derivative.expiration_date: Each performance right represents a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vest at a rate between 0% and 200% during a three-year performance cycle beginning on April 1, 2017 and ending on March 31, 2020 based on the issuer's relative total shareholder return in comparison to the total shareholder return performance among the Russell 2000 Index over the performance cycle. The performance rights may be settled, at the issuer's discretion, in cash or shares of common stock. Read SEC document |
| April 05, 2017 Filed Apr 5, 2017 22:15 UTC |
MUDD CHRISTOPHER JPresident and COO
|
GrantPerformance Rights · Derivative | 10,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001593968-17-000579 · primary_01.xml · derivative · entry 1 MUDD CHRISTOPHER J · CIK 0001630422 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,696 Underlying: Common Stock · 10,000 shares Expires not disclosed F1 · derivative.exercise_price: Each performance right represents a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vest at a rate between 0% and 200% during a three-year performance cycle beginning on April 1, 2017 and ending on March 31, 2020 based on the issuer's relative total shareholder return in comparison to the total shareholder return performance among the Russell 2000 Index over the performance cycle. The performance rights may be settled, at the issuer's discretion, in cash or shares of common stock. F2 · derivative.exercise_date: Each performance right represents a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vest at a rate between 0% and 200% during a three-year performance cycle beginning on April 1, 2017 and ending on March 31, 2020 based on the issuer's relative total shareholder return in comparison to the total shareholder return performance among the Russell 2000 Index over the performance cycle. The performance rights may be settled, at the issuer's discretion, in cash or shares of common stock. F2 · derivative.expiration_date: Each performance right represents a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vest at a rate between 0% and 200% during a three-year performance cycle beginning on April 1, 2017 and ending on March 31, 2020 based on the issuer's relative total shareholder return in comparison to the total shareholder return performance among the Russell 2000 Index over the performance cycle. The performance rights may be settled, at the issuer's discretion, in cash or shares of common stock. Read SEC document |
| April 05, 2017 Filed Apr 5, 2017 22:16 UTC |
Sullivan DonSVP & GM, Ind. Products
|
GrantPerformance Rights · Derivative | 3,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001593968-17-000580 · primary_01.xml · derivative · entry 1 Sullivan Don · CIK 0001663176 · SVP & GM, Ind. Products 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,481 Underlying: Common Stock · 3,000 shares Expires not disclosed F1 · derivative.exercise_price: Each performance right represents a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vest at a rate between 0% and 200% during a three-year performance cycle beginning on April 1, 2017 and ending on March 31, 2020 based on the issuer's relative total shareholder return in comparison to the total shareholder return performance among the Russell 2000 Index over the performance cycle. The performance rights may be settled, at the issuer's discretion, in cash or shares of common stock. F2 · derivative.exercise_date: Each performance right represents a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vest at a rate between 0% and 200% during a three-year performance cycle beginning on April 1, 2017 and ending on March 31, 2020 based on the issuer's relative total shareholder return in comparison to the total shareholder return performance among the Russell 2000 Index over the performance cycle. The performance rights may be settled, at the issuer's discretion, in cash or shares of common stock. F2 · derivative.expiration_date: Each performance right represents a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vest at a rate between 0% and 200% during a three-year performance cycle beginning on April 1, 2017 and ending on March 31, 2020 based on the issuer's relative total shareholder return in comparison to the total shareholder return performance among the Russell 2000 Index over the performance cycle. The performance rights may be settled, at the issuer's discretion, in cash or shares of common stock. Read SEC document |
| February 28, 2017 Filed Mar 1, 2017 23:00 UTC |
Alverson LukeSVP, GC & Secretary
|
Tax withholdingCommon Stock | 573 | $37.10 | $21,258.30 |
DisclosureSEC source: 0001593968-17-000367 · primary_01.xml · nonDerivative · entry 1 Alverson Luke · CIK 0001668461 · SVP, GC & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,005 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.